Heat treatment of samples improve the performance of the Nijmegen–Bethesda assay in hemophilia A patients undergoing immune tolerance induction-Reference-Cited by-同舟云学术

Heat treatment of samples improve the performance of the Nijmegen–Bethesda assay in hemophilia A patients undergoing immune tolerance induction

Published:2015-12 Issue:6 Volume:136 Page:1280-1284
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

de Lima Montalvão Silmara Aparecida^ORCID,Tucunduva Alini Camargo,de Almeida Sambo Andrea Luísa,De Paula Erich Vinicius,de Souza Medina Samuel,Ozelo Margareth Castro

Publisher

Elsevier BV

Subject

Hematology

Reference10 articles.

1. Proceedings: a more uniform measurement of factor VIII inhibitors;Kasper;Thromb. Diath. Haemorrh.,1975

2. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability;Verbruggen;Thromb. Haemost.,1995

3. Interlaboratory variation in factor VIII:C inhibitor assay results is sufficient to influence patient management: data from the UK national quality external assessment scheme for blood coagulation;Kitchen;Semin. Thromb. Hemost.,2009

4. The between-laboratory variation of factor VIII inhibitor testing: the experience of the external quality assessment program of the ECAT foundation;Meijer;Semin. Thromb. Hemost.,2009

5. Validation of Nijmegen–Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance;Miller;J. Thromb. Haemost.,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors;International Journal of Laboratory Hematology;2023-06-07

2. Immunogenicity of Current and New Therapies for Hemophilia A;Pharmaceuticals;2022-07-23

3. Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy;International Journal of Hematology;2022-05-03

4. Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey;Haemophilia;2021-03-02

5. Heat inactivation of extended half‐life factor VIII concentrates;Haemophilia;2019-02-12